✉ Email this page to a colleague
« Back to Dashboard
Benzene Hexacarboxylic Acid is an investigational drug.
There have been 4 clinical trials for Benzene Hexacarboxylic Acid. The most recent clinical trial was a Phase 2 trial, which was initiated on December 28th 2010.
The most common disease conditions in clinical trials are Leukemia, Erythroblastic, Acute, Myelodysplastic Syndromes, and Leukemia. The leading clinical trial sponsors are Norwegian University of Life Sciences, Meabco A/S, and Summa Health System.
Recent Clinical Trials for Benzene Hexacarboxylic Acid
|Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Premature Puberty||Uppsala-Örebro Regional Research Council||N/A|
|Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Premature Puberty||Region Örebro County||N/A|
|BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer||Meddoc||Phase 2|